Impact of diabetes on cognitive function and brain structure

Annals of the New York Academy of Sciences

Volumn 1353, Issue 1, 2015, Pages 60-71

  Moheet, Amir ^a   Mangia, Silvia ^a   Seaquist, Elizabeth R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Brain; Cognitive dysfunction; Memory; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

DEOXYHEMOGLOBIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; ATTENTION; BOLD SIGNAL; BRAIN; BRAIN ATROPHY; BRAIN DISEASE; BRAIN SIZE; CINGULUM (BRAIN); COGNITION; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DEFAULT MODE NETWORK; DEPTH PERCEPTION; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIFFUSION TENSOR IMAGING; EXECUTIVE FUNCTION; EXECUTIVE FUNCTION TEST; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLYCEMIC CONTROL; GRAY MATTER; HUMAN; HYPERTENSION; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; LEARNING; LONGITUDINAL STUDY; MEMORY; METABOLIC REGULATION; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; POSTERIOR CINGULATE; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); UNCINATE FASCICULUS; VERBAL MEMORY; WHITE MATTER; PATHOLOGY;

BRAIN; COGNITION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS;

EID: 84945479161     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12807     Document Type: Article

References (98)

1. Biessels, G.J. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5: 64-74.
2. Miles, W.R. & H.F. Root . 1922. Psychologic tests applied to diabetic patients. Arch. Intern. Med. 30: 767-777.
3. Dejong, R. 1950. The nervous system complications of diabetes mellitus, with special reference to cerebrovascular changes. J. Nerv. Ment. Dis. 111: 181-206.
4. Mijnhout, G.S., P. Scheltens, M. Diamant, et al. 2006. Diabetic encephalopathy: a concept in need of a definition. Diabetologia 49: 1447-8.
5. Jacobson, A., G. Musen, C. Ryan, et al. 2007. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 356: 1842-52.
6. Reichard, P., M. Pihl, U. Rosenqvist, et al. 1996. Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up. Diabetologia 39: 1483-1488.
7. Arbelaez, A.M., K. Semenkovich & T. Hershey . 2013. Glycemic extremes in youth with T1DM: the structural and functional integrity of the developing brain. Pediat. Diab. 14: 541-553.
8. Musen, G., A.M. Jacobson, C.M. Ryan, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. 2008. Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial. Diab. Care 31: 1933-1938.
9. Ryan, C.M., M.O. Geckle & T.J. Orchard . 2003. Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46: 940-948.
10. Ryan, C.M., T.M. Williams, D.N. Finegold, et al. 1993. Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 36: 329-34.
11. Perantie, D.C., A. Lim, J. Wu, et al. 2008. Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediat. Diab. 9: 87-95.
12. Northam, E., D. Rankins, A. Lin, et al. 2009. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diab. Care 32: 445-50.
13. Ohmann, S., C. Popow, B. Rami, et al. 2010. Cognitive functions and glycemic control in children and adolescents with type 1 diabetes. Psychol. Med. 40: 95-103.
14. Wessels, A.M., S.A. Rombouts, P.L. Remijnse, et al. 2007. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 50: 1763-1769.
15. Brands, A.M., G.J. Biessels, E.H. de Haan, et al. 2005. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diab. Care 28: 726-735.
16. Gaudieri, P.A. 2008. Cognitive function in children with type 1 diabetes: a meta-analysis. Diab. Care 31: 1892-1897.
17. Nooyens, A.C., C.A. Baan, A.M. Spijkerman, et al. 2010. Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study. Diab. Care 33: 1964-1969.
18. Kanaya, A.M. 2004. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch. Intern. Med. 164: 1327-1333.
19. Gregg, E.W., K. Yaffe, J.A. Cauley, et al. 2000. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch. Intern. Med. 160: 174-180.
20. Hassing L., M. Grant, S. Hofer, et al. 2004. Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J. Intl. Neuropsychol. Soc. 10: 599-607.
21. van den Berg, E., Y.D. Reijmer, J. de Bresser, et al. 2010. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 53: 58-65.
22. Launer L., M. Miller, J. Williamson, et al. 2011. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 10: 969-977.
23. Cukierman-Yaffe, T., H. Gerstein, J. Williamson, et al. 2009. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diab. Care 32: 221-226.
24. Hugenschmidt, C.E., J.F. Lovato, W.T. Ambrosius, et al. 2014. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the action to control cardiovascular risk in diabetes (ACCORD) trial. Diab. Care 37: 3244-3252.
25. Patton, N., T. Aslam, T. MacGillivray, et al. 2005. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J. Anat. 206: 319-348.
26. Fontbonne, A., C. Berr, P. Ducimetire, et al. 2001. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the epidemiology of vascular aging study. Diab. Care 24: 366-370.
27. Rawlings, A.M., A.R. Sharrett, A.L.C. Schneider, et al. 2014. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann. Intern. Med. 161: 785-U68.
28. Ott, A., R.P. Stolk, F. van Harskamp, et al. 1999. Diabetes mellitus and the risk of dementia-the Rotterdam study. Neurology 53: 1937-1942.
29. Manschot, S.M., A.M.A. Brands, J. van der Grond, et al. 2006. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55: 1106-1113.
30. Reaven, G.M., L.W. Thompson, D. Nahum, et al. 1990. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diab. Care 13: 16-21.
31. Ebady, S. 2009. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diab. Res. Clin. Pract. 82: 305.
32. Grodstein, F., R.S. Wilson, J. Chen, et al. 2001. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diab. Care 24: 1060-1065.
33. Ruis, C., G.J. Biessels, K.J. Gorter, et al. 2009. Cognition in the early stage of type 2 diabetes. Diab. Care 32: 1261-1265.
34. Ding, J., M.W.J. Strachan, R. Reynolds, et al. 2010. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes 59: 2883.
35. Perlmuter, L.C., M.K. Hakami, C. Hodgson-Harrington, et al. 1984. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am. J. Med. 77: 1043-1048.
36. Kivipelto, M., E.L. Helkala, T. Hnninen, et al. 2001. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 56: 1683-1689.
37. DeCarli, C., B.L. Miller, G.E. Swan, et al. 2001. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch. Neurol. 58: 643-647.
38. Hill, C.D., A. Stoudemire, R. Morris, et al. 1993. Similarities and differences in memory deficits in patients with primary dementia and depression-related cognitive dysfunction. J. Neuropsychiatry Clin. Neurosci. 5: 277-282.
39. Yaffe, K., T. Blackwell, A.M. Kanaya, et al. 2004. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63: 658-663.
40. Yau, P.L., D.C. Javier, C.M. Ryan, et al. 2010. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 53: 2298-2306
41. Ryan, C.M. & M. Geckle . 2000. Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? Diabetes Metab. Res. Rev. 16: 308-315.
42. van den Berg, E., R.P. Kloppenborg, R.P.C. Kessels, et al. 2009. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim. Biophys. Acta-Mol. Basis Dis. 1792: 470-481.
43. Palta, P., A.L.C. Schneider, G.J. Biessels, et al. 2014. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J. Intl. Neuropsychol. Soc. 20: 278-291.
44. Musen, G., I. Lyoo, C. Sparks, et al. 2006. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55: 326-333.
45. Hughes, T.M., C.M. Ryan, H.J. Aizenstein, et al. 2013. Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications. J. Diab. Compl. 27: 558-564.
46. Wessels, A.M., S. Simsek, P.L. Remijnse, et al. 2006. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49: 2474-2480.
47. Marzelli, M.J., P.K. Mazaika, N. Barnea-Goraly, et al. 2014. Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes 63: 343-353.
48. Pantoni, L. & J.H. Garcia . 1997. Pathogenesis of leukoaraiosis: a review. Stroke 28: 652-659.
49. Jeerakathil, T., P. Wolf, A. Beiser, et al. 2004. Stroke risk profile predicts white matter hyperintensity volume: the Framingham study. Stroke 35: 1857-1861.
50. Dejgaard, A., A. Gade, H. Larsson, et al. 1991. Evidence for diabetic encephalopathy. Diab. Med. 8: 162-167.
51. Weinger, K., A.M. Jacobson, G. Musen, et al. 2008. The effects of type 1 diabetes on cerebral white matter. Diabetologia 51: 417-425.
52. Lobnig, B.M., O. Krmeke, C. Optenhostert-Porst, et al. 2006. Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications. Diab. Med. 23: 32-39.
53. Hershey, T., D. Perantie, J. Wu, et al. 2010. Hippocampal volumes in youth with type 1 diabetes. Diabetes 59: 236-241.
54. Kodl, C., D. Franc, J. Rao, et al. 2008. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 57: 3083-3089.
55. Mangia, S., A.F. Kumar, A.A. Moheet, et al. 2013. Neurochemical profile of patients with type 1 diabetes measured by H-1-MRS at 4 T. J. Cereb. Blood Flow Metab. 33: 754-759.
56. Ogawa, S, T.M. Lee, A.R. Kay, et al. 1990. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. U.S.A. 87: 9868-9872.
57. Damoiseaux, J.S., S.A. Rombouts, F. Barkhof, et al. 2006. Consistent resting-state networks across healthy subjects. Proc. Natl. Acad. Sci. U.S.A. 103: 13848-13853.
58. Raichle, M.E., A.M. MacLeod, A.Z. Snyder, et al. 2001. A default mode of brain function. Proc. Natl. Acad. Sci. U.S.A. 98: 676-682.
59. Gusnard, D.A., M.E. Raichle & M.E. Raichle . 2001. Searching for a baseline: functional imaging and the resting human brain. Nat. Rev. Neurosci. 2: 685-694.
60. Greicius, M.D., B. Krasnow, A.L. Reiss, et al. 2003. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc. Natl. Acad. Sci. U.S.A. 100: 253-258.
61. Badgaiyan, R.D. & M.I. Posner . 1998. Mapping the cingulate cortex in response selection and monitoring. Neuroimage. 7: 255-260.
62. McKiernan, K.A., J.N. Kaufman, J. Kucera-Thompson, et al. 2003. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J. Cogn. Neurosci. 15: 394-408.
63. Cauda, F., F. D'Agata, K. Sacco, et al. 2010. Altered resting state attentional networks in diabetic neuropathic pain. J. Neurol. Neurosurg. Psychiat. 81: 806-811.
64. van Duinkerken, E., M.M. Schoonheim, E.J. Sanz-Arigita, et al. 2012. Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes 61: 1814-1821.
65. van Duinkerken, E., R.G. Ijzerman, N.J. van der Zijl, et al. 2014. Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy. Cardiovasc. Diabetol. 13: 58.
66. Moran, C., T.G. Phan, J. Chen, et al. 2013. Brain atrophy in type 2 diabetes regional distribution and influence on cognition. Diab. Care 36: 4036-4042.
67. den Heijer, T., S.E. Vermeer, E.J. van Dijk, et al. 2003. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46: 1604-1610.
68. Brundel, M., M. van den Heuvel, J. de Bresser, et al. 2010. Cerebral cortical thickness in patients with type 2 diabetes. J. Neurol. Sci. 299: 126-130.
69. Manschot, S.M., G.J. Biessels, H. de Valk, et al. 2007. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 50: 2388-2397.
70. Schmidt, R., L. Launer, L. Nilsson, et al. 2004. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) study. Diabetes 53: 687-692.
71. van Elderen, S.G.C., A. de Roos, A.J.M. de Craen, et al. 2010. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 75: 997.
72. Reijmer, Y.D., E. van den Berg, J. de Bresser, et al. 2011. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Diabetes Metab. Res. Rev. 27: 195-202.
73. Kooistra, M., M.I. Geerlings, W.P.T.M. Mali, et al. 2013. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study.J. Neurol. Sci. 332: 69-74.
74. de Bresser J., A.M. Tiehuis, E. van den Berg, et al. 2010. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diab. Care 33: 1309-1314.
75. Brundel, M., Y.D. Reijmer, S.J. van Veluw, et al. 2014. Cerebral microvascular lesions on high-resolution 7-tesla MRI in patients with type 2 diabetes. Diabetes 63: 3523-3529.
76. Reijmer, Y.D., M. Brundel, J. de Bresser, et al. 2013. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes a diffusion tensor imaging study. Diab. Care 36: 137-144.
77. Reijmer, Y.D., A. Leemans, M. Brundel, et al. 2013. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes 62: 2112-2115.
78. Greicius, M.D., B. Krasnow, A.L. Reiss, et al. 2003. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc. Natl. Acad. Sci. U.S.A. 100: 253-258.
79. Sorg, C, V. Riedl, M. Muhlau, et al. 2007. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 104: 18760-18765.
80. Musen, G., A.M. Jacobson, N.R. Bolo, et al. 2012. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 61: 2375-2379.
81. Hoogenboom, W.S., T.J. Marder, V.L. Flores, et al. 2014. Cerebral white matter integrity and resting-state functional connectivity in middle-aged patients with type 2 diabetes. Diabetes 63: 728-738.
82. Chen, Y.C., Y. Jiao, Y. Cui, et al. 2014. Aberrant brain functional connectivity related to insulin resistance in type 2 diabetes: a resting-state fMRI study. Diab. Care 37: 1689-1696.
83. Marder, T.J., V.L. Flores, N.R. Bolo, et al. 2014. Task-induced brain activity patterns in type 2 diabetes: a potential biomarker for cognitive decline. Diabetes 63: 3112-3119.
84. Zhou, H., W. Lu, Y. Shi, et al. 2010. Impairments in cognition and resting-state connectivity of the hippocampus in elderly subjects with type 2 diabetes. Neurosci. Lett. 473: 5-10.
85. Cukierman, T, H.C. Gerstein & J.D. Williamson . 2005. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48: 2460-2469.
86. Curb, J.D., B.L. Rodriguez, R.D. Abbott, et al. 1999. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 52: 971-975.
87. Luchsinger, J.A., M.X. Tang, Y. Stern, et al. 2001. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 154: 635-641.
88. Kuusisto, J., K. Koivisto, L. Mykkanen, et al. 1997. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. Br. Med. J. 315: 1045-1049.
89. Ott, A., R.P. Stolk, A. Hofman, et al. 1996. Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 39: 1392-1397.
90. Yoshitake, T., Y. Kiyohara, I. Kato, et al. 1995. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 45: 1161-1168.
91. Cui, Y, Y. Jiao, Y.C. Chen, et al. 2014. Altered spontaneous brain activity in type 2 diabetes: a resting-state functional MRI study. Diabetes 63: 749-760.
92. Xia, W., S. Wang, Z. Sun, et al. 2013. Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study. Psychoneuroendocrinology 38: 2493-2501.
93. Wang, C., K. Fu, H. Liu, et al. 2014. Spontaneous brain activity in type 2 diabetics revealed by amplitude of low-frequency fluctuations and its association with diabetic vascular disease: a resting-state fMRI study. PLoS One 9: e108883.
94. Baker, L.D., D.J. Cross, S. Minoshima, et al. 2011. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch. Neurol. 68: 51-57.
95. Kodl, C.T. & E.R. Seaquist . 2008. Cognitive dysfunction and diabetes mellitus. Endocr. Rev. 29: 494-511.
96. McCrimmon, R.J., C.M. Ryan & B.M. Frier . 2012. Diabetes and cognitive dysfunction. Lancet 379: 2291-2299.
97. Ryan, C., A. Vega, A. Drash . 1985. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 75: 921-927.
98. Sinclair, A.J., A.J. Girling, A. Bayer . 2000. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. Diab. Res. Clin. Pract. 50: 203-212.